TickerFacts.

Oncotelic Therapeutics, Inc. (OTLC): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

422.23M
Year ended 2025-12-31
-2.6%
3-year compound annual growth
457.30M2021-12-31: 303.08M2022-12-31: 457.30M2023-12-31: 396.17M2024-12-31: 404.40M2025-12-31: 422.23M422.23M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31422.23M+4.4%2026-04-15, From 2025-01-01
2024-12-31404.40M+2.1%2026-04-15, From 2024-01-01
2023-12-31396.17M-13.4%2024-04-12, From 2023-01-01
2022-12-31457.30Mn/c2024-04-12, From 2022-01-01
2021-12-31303.08Mn/a2023-04-20, From 2021-01-01